Cite
HARVARD Citation
Baroncini, D. et al. (2016). A real world experience with fingolimod in active RRMS patients naïve to second-line agents: a 2 years, intention-to-treat, observational, single center study. Multiple sclerosis and demyelinating disorders. 1 (1), pp. 1-5. [Online].